Which funds bought or sold ORCL in Q3 2026?
Oracle Corp. 22 funds bought, 13 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$4.1B. See also what famous investors say about ORCL.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- Capital Research+$3.8B
- AQR+$1.1B
- Amundi+$671M
- BlackRock+$657M
- Jane Street+$411M
- Marshall Wace+$399M
- Susquehanna+$370M
- GQGNEW+$341M
- Bank of America+$340M
- D. E. Shaw+$315M
- Jennison−$789M
- JPMorgan−$604M
- Goldman Sachs−$537M
- Point72−$433M
- UBS−$274M
- Citadel−$240M
- AllianceBernstein−$225M
- Wells Fargo−$179M
- Tudor−$158M
- Ameriprise−$155M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (22)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Capital Research Asset manager | Added+70% | +$3.8B | $9.3B |
| AQR Quant & multi-strategy | Added+288.6% | +$1.1B | $1.5B |
| Amundi Asset manager | Added+49.5% | +$671M | $2.0B |
| BlackRock Index giant | Added+3.3% | +$657M | $20.6B |
| Jane Street Quant & multi-strategy | Added+47.7% | +$411M | $1.3B |
| Marshall Wace Quant & multi-strategy | Added+300.2% | +$399M | $532M |
| Susquehanna Quant & multi-strategy | Added+51% | +$370M | $1.1B |
| GQG Growth / crossover | New | +$341M | $341M |
| Bank of America Bank & broker | Added+10.3% | +$340M | $3.6B |
| D. E. Shaw Quant & multi-strategy | Added+75.6% | +$315M | $732M |
| First Eagle Value investor | Added+17.8% | +$208M | $1.4B |
| Appaloosa Hedge fund | New | +$172M | $172M |
| QRT Quant & multi-strategy | Added+48.6% | +$159M | $487M |
| Geode Index giant | Added+2.9% | +$157M | $5.5B |
| CalPERS Sovereign & pension | Added+33.6% | +$115M | $457M |
| CPP Investments Sovereign & pension | Added+20.6% | +$107M | $625M |
| RBC Bank & broker | Added+9.7% | +$83M | $935M |
| Glenview Hedge fund | New | +$74M | $74M |
| Fisher Investments Asset manager | Added+3.1% | +$56M | $1.9B |
| Man Group Quant & multi-strategy | Added+203.1% | +$53M | $79M |
| PRIMECAP Growth / crossover | Added+4.6% | +$34M | $773M |
| Light Street Growth / crossover | New | +$19M | $19M |
Sold (13)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Jennison Growth / crossover | Trimmed-99.2% | −$789M | $6M |
| JPMorgan Bank & broker | Trimmed-19.1% | −$604M | $2.6B |
| Goldman Sachs Bank & broker | Trimmed-18.4% | −$537M | $2.4B |
| Point72 Quant & multi-strategy | Trimmed-92.6% | −$433M | $35M |
| UBS Bank & broker | Trimmed-14.9% | −$274M | $1.6B |
| Citadel Quant & multi-strategy | Trimmed-36.8% | −$240M | $413M |
| AllianceBernstein Asset manager | Trimmed-33.7% | −$225M | $443M |
| Wells Fargo Bank & broker | Trimmed-16.8% | −$179M | $887M |
| Tudor Hedge fund | Trimmed-91.3% | −$158M | $15M |
| Ameriprise Asset manager | Trimmed-17.5% | −$155M | $730M |
| Polen Growth / crossover | Trimmed-29.5% | −$145M | $346M |
| Bridgewater Hedge fund | Trimmed-17.6% | −$35M | $162M |
| ExodusPoint Quant & multi-strategy | Sold out | −$27M | — |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.